title: [Drug treatment of frequent disorders in patients with Parkinson's disease].
abstract: The patient with Parkinson's disease often needs concomitant treatment for disorders that accompany the disease, such as depression, insomnia or constipation, or for frequent concomitant alterations such as dizziness, high blood pressure or heart disease. The many drugs that can worsen motor symptoms in Parkinson's disease must be avoided, especially if use will be prolonged. Not all drugs that induce or aggravate parkinsonism have the same potency. We describe 3 groups: 1) drugs that invariably induce or aggravate parkinsonism if taken long enough or at high enough doses; 2) drugs that only provoke parkinsonism in some individuals, and 3) drugs that interfere with the action of levodopa. Knowledge of these drugs is essential for all doctors who treat patients with Parkinson's disease.
authors.affiliation: Servicio de Neurología, Hospital Nuestra Señora de Aránzazu, San Sebastián.
authors.forename: J F
authors.initials: JF
authors.lastname: Martí Massó
authors.forename: J J
authors.initials: JJ
authors.lastname: Poza
authors.forename: A
authors.initials: A
authors.lastname: López de Munain
mesh_terms: D000927:Anticonvulsants / Q000627:therapeutic use; D000928:Antidepressive Agents / Q000009:adverse effects; D000959:Antihypertensive Agents / Q000009:adverse effects; D014150:Antipsychotic Agents / Q000009:adverse effects; D002121:Calcium Channel Blockers / Q000009:adverse effects; D003866:Depressive Disorder / Q000188:drug therapy / Q000523:psychology; D006801:Humans; D007980:Levodopa / Q000627:therapeutic use; D010300:Parkinson Disease / Q000188:drug therapy / Q000523:psychology; D010302:Parkinson Disease, Secondary / Q000209:etiology; D014149:Tranquilizing Agents / Q000009:adverse effects
chemical_list: D000927:Anticonvulsants; D000928:Antidepressive Agents; D000959:Antihypertensive Agents; D014150:Antipsychotic Agents; D002121:Calcium Channel Blockers; D014149:Tranquilizing Agents; D007980:Levodopa
vernacular_title: Uso de fármacos para trastornos frecuentes en el paciente con enfermedad de Parkinson.